Lumos Diagnostics (ASX:LDX) Announces Q4 FY25 Financial Results and Major Distribution Agreement
Lumos Diagnostics (ASX:LDX) reports Q4 FY25 revenue of US$2.6M, secures major US distribution deal, and advances FebriDx CLIA waiver study.
Lumos Diagnostics (ASX:LDX) reports Q4 FY25 revenue of US$2.6M, secures major US distribution deal, and advances FebriDx CLIA waiver study.
Patriot Battery Metals (ASX:PMT) announces the world’s largest pollucite-hosted caesium pegmatite resource, signalling significant growth.
PYC Therapeutics (ASX:PYC) updates shareholders on significant clinical progress and a strong financial position in Q2 2025.
AMP Limited (ASX:AMP) reports a 63.2% increase in 2Q25 cashflows, emphasizing growth in Platforms and Superannuation sectors.
Brightstar Resources (ASX:BTR) reports a 25% increase in production at Second Fortune and discovers new FTV Lode, enhancing future growth prospects.
Asra Minerals (ASX:ASR) starts a 3,000m drilling campaign at Leonora South to confirm gold mineralisation, with assays due in August.
Adisyn Ltd (ASX:AI1) commissions a new ALD system, enhancing its graphene research for advancing semiconductor technologies.
Janison Education Group Limited (ASX:JAN) has been awarded a contract by the New Zealand Ministry of Education to deliver a new digital assessment tool for schools.
Athena Resources (ASX:AHN) partners with Warradarge Energy and Fenix to develop the Mid West Green Iron Project in Western Australia.
Proteomics International (ASX:PIQ) unveils the OxiDx test for detecting muscle damage in racehorses, targeting an Australian launch in H2 CY25.